Lymphatic system is physiologically essential for the preservation of the isohydria, nutrient uptake and immune surveillance.
Although the roles of several growth factors in corneal lymphangiogenesis have been extensively researched, including vascular endothelial growth factor-C (VEGF-C), fibroblast growth factor-2 and platelet-derived growth factor-BB, [10] [11] [12] [13] the regulatory role of extracellular matrix (ECM) molecules in corneal lymphangiogenesis has not been widely evaluated. The newly formed lymphatics are closely linked to the ECM environment due to the absence of a basement membrane and pericytes. Thus, recent studies on the molecular regulation of lymphangiogenesis have focused on the interaction between lymphatic endothelial cells (LECs) and the ECM microenvironment. ECM molecules including hyaluronan, integrins, galectin-8, matrix metalloproteinases and fibronectin (FN) play a pivotal role in lymphangiogenesis process by regulating LECs' proliferation, migration and tube formation. [14] [15] [16] [17] [18] Transforming growth factor-β-induced protein (TGFBIp) is widely expressed in vivo as a kind of ECM protein. It is distributed in corneal epithelium physiologically 19 and has been found to be overexpressed in a variety of tumours and inflammatory diseases, presenting a certain regulatory effect on cell adhesion, migration and differentiation. [20] [21] [22] [23] [24] TGFBIp contains a highly conserved RGD peptide in the C' section. The RGD peptide is also present in the FN domain, which can be identified by integrin and then mediate FN to induce the sprouting and directional migration of LECs 18 In previous studies, it has been reported that LECs express several subtypes of integrin which participate in the pathological process of corneal lymphangiogenesis. 25, 26 However, the interaction between LECs, TGFBIp and binding-receptor integrin is not well understood.
Although previous study found that the inhibition of TGFBIp expression reduces tumour lymphangiogenesis, 27 its precise function in corneal LG remains obscure. In our current study, a suture-induced corneal lymphangiogenesis model was used to explore TGFBIp expression in the corneal tissue during the process of inflammationinduced lymphangiogenesis. The corneal micropocket assay was used to investigate its regulatory role in corneal lymphangiogenesis in vivo. Additionally, in vitro assays, including cell proliferation, adhesion, migration and tube formation, were conducted to investigate the effect of TGFBIp on the biological behaviour of human lymphatic endothelial cells (HLECs) and to preliminarily explore the integrin-mediated signalling pathways stimulated by TGFBIp. Our current study exploring the regulatory role of TGFBIp in inflammatory corneal lymphangiogenesis may provide a new target for inhibiting corneal lymphangiogenesis and thus lay a foundation for the clinical treatment of lymphatic-associated disorders.
| MATERIAL S AND ME THODS

| Animals
Mice were treated according to the ARVO Statement for the Use of Hospital of Fudan University. Mice were anaesthetized using a mixture of ketamine and xylazine (50 mg and 10 mg/kg body weight, respectively) for each surgical procedure. Six-to eight-week-old male C57BL/6 mice (Laboratory Animal Centre of the Chinese Academy of Sciences in Shanghai, China) were used throughout the study.
| Cell culture
Primary HLECs were purchased from PromoCell and cultured in endothelial basal medium (EBM; Lonza) supplemented with 10% foetal calf serum (FCS; Biowest) and other supplements, as previously described. 28 HLECs at passages 4-8 were used in this study.
| Corneal suture placement
The standard suture placement model was used to induce corneal inflammatory lymphangiogenesis in C57BL/6 mice as described previously. 10, 25 Briefly, three interrupted sutures (11-0 nylon; Ningbo Medical Needle Co., Ltd.) were placed in the corneal stroma 2 mm away from the limbus without penetrating the anterior chamber to obtain standardized lymphangiogenic responses ( Figure 1A ).
| Mouse corneal micropocket assay and pharmaceutical interventions
The mouse corneal micropocket assay was performed in C57BL/6 mice as previously described. 29 Test agents included recombinant TGFBIp (40, 80, 160 , 320 ng per pellet; R&D Systems) and VEGF-C (160 ng per pellet; PeproTech). The mouse corneal micropocket assay was surgically created on a single eye of each animal (five mice per group). Implants containing hydron and sucralfate alone served as negative controls. The mice were anaesthetized by intraperitoneal injection of a cocktail of ketamine and xylazine. The eyes were topically anaesthetized with 0.4% oxybuprocaine. Using a corneal blade, intrastromal linear keratotomy was performed approximately 2 mm from the limbus. A pocket was extended towards the limbus using a von Graefe knife, and the pellet was embedded into the pocket. The wound was coated with ofloxacin ophthalmic ointment (Shenyang Xingqi Pharmaceutical Co., Ltd.) to prevent infection. In the combination study, 160 ng TGFBIp and 160 ng VEGF-C were co-implanted into each micropocket (five mice per group). For the inhibition study, mice were concurrently injected intraperitoneally with vehicle or integrin α5β1 blocking antibodies (MFR5, 600 μg per mouse; BD Biosciences) on postoperative days 0, 2 and 4. The area of corneal lymphangiogenesis and quantity of lymphatic vessel sprouting were evaluated on day 7 after pellet implantation.
| Local depletion of macrophages using subconjunctival clodronate liposomes
Local depletion of macrophages was accomplished as described previously. 30 Clodronate liposomes (10 μL; Liposoma) was injected subconjunctivally with a microsyringe at the time of suture placement and 2, 4 and 6 days after surgery. Mice in the control group received liposomes containing PBS subconjunctivally at the same timepoints. To confirm whether subconjunctival clodronate liposomes could lead to local depletion of macrophages, immunohistochemistry was performed on corneal whole mounts at 7 days after corneal suture placement for both groups (n = 5 each group) with the macrophage marker (rat antimouse F4/80 antibody; AbD Serotec).
Simultaneously, Western blot analysis was conducted to detect the expression change in TGFBIp in the mouse cornea after suture placement in both groups (n = 5 in each group). Additionally, corneal immunofluorescence was conducted with corneal whole mounts to evaluate corneal lymphangiogenesis and haemangiogenesis in both groups (n = 5 in each group).
| Quantitative PCR analysis
The quantitative PCR assays were performed to measure the expression levels of TGFBIp and β-actin. Total RNA was extracted with 
| Western blot analysis
Western blot analysis was conducted to detect the expression change in TGFBIp in the mouse cornea at day 3 (n = 5), day 7
(n = 5) and day 14 (n = 5) after suture placement, and it was also 
| TGFBIp immunohistochemistry staining of frozen corneal sections
| F4/80 immunohistochemical staining
For characterization of inflammatory cells recruited to the cornea, immunohistochemistry was performed on corneal whole mounts with the macrophage markers F4/80 (AbD Serotec). 31 For identification of the intracorneal source of the ECM protein-TGFBIp, immunohistochemistry of both TGFBIp (1:100 dilution; Abcam) and the macrophage markers F4/80 (1:100 dilution; AbD Serotec) mentioned above was performed on whole mounts of cornea at 7 days after corneal suture placement. The whole mounts of cornea were evaluated using confocal microscopy (Leica TCS-SP8).
Macrophage recruitment was also evaluated as previously described. 32 Briefly, 10 areas (eight from the periphery and two from the centre) of each sample were randomly picked and examined under an epifluorescence microscope, and the total numbers of F4/80-positive cells were counted throughout the whole thickness of the selected area.
| Corneal immunofluorescence assay and quantification
Corneal whole mounts were used to evaluate corneal neovascularization (lymphangiogenesis and angiogenesis) and lymphatic vessel sprouting. Whole-mount staining was performed according to our previously described methods. 28 Mice were killed at the planned times, and the eyes were removed and dissected; subsequently, whole-mounted corneas were fixed in 4% paraformaldehyde over- Flat mounted corneas on a microscope slide with anti-fade solution (AR1109; Boster) were examined using a confocal microscope (TCS-SP8; Leica). Images were obtained at 100× magnification and automatically assembled to reconstitute the whole cornea. The area of corneal lymphangiogenesis and angiogenesis was quantified as described previously using ImageJ software to evaluate the coverage area. 10, 33, 34 Lymphatic vessel sprouting was evaluated as follows.
Briefly, three areas of each sample on the planted side of the cornea were randomly picked and examined under an epifluorescence microscope, and the total numbers of sprouting lymphatic vessel were counted in the selected area.
| LEC proliferation assay
The CCK8-based proliferation assay was used for our study. Briefly, 1 × 10 4 HLECs were seeded into each well of a 96-well plate in a total volume of 200 μL of medium containing 2% (vol/vol) FCS for 4-6 days. The cells were treated with or without rhTGFBIp (1, 5, or 10 μg/mL). Untreated cells were used as negative controls. After incubation at 37°C for 24, 36 or 48 hours, 10 μL of CCK-8 (5 mg/mL; Dojindo) was added to each well, and samples were further incubated for 2 hours. The absorbance of the purple formazan solution at a wavelength of 450 nm was measured (n = 6 per group).
| LEC migration assay
The wound-healing assay was performed to evaluate the LEC mi- 
| LEC adhesion assay
Cell-matrix adhesion assays were performed as described previously. 35 The 96-well plates were coated overnight (4°C) with 1-10 μg/mL rhTGFBIp. LECs in adhesion buffer (serum-free media)
were seeded with 10 5 cells/well in a 100-μL volume and incubated for 30 minutes at 37°C. After the removal of non-adherent cells after two washes, adherent cells were measured by DAPI staining and quantified in triplicate by counting adherent cells in five randomly selected fields per well. For the comparative study, 5 μg/mL rhTGFBIp or rhFN was added. For the blocking experiments, the experiments were performed with or without 1 μg/mL mouse anti-integrin α5β1 monoclonal antibody, 1 μg/mL mouse anti-integrin α4β1 monoclonal antibody or 1 μmol/L FAK inhibitor.
The results are representative of three different experiments in duplicate.
| LEC tube formation assay
Tube formation was assayed as previously described. 27 In brief, 
| Statistical analysis
Statistical data were analysed using SPSS 19.0 (SPSS). Results were expressed as means ± SD. ANOVA followed by Bonferroni posttests was performed for analysis of three or more groups. Unpaired
Student's t test (Mann-Whitney) was used when only two experimental groups were analysed. A value of P < .05 was considered as statistically significant.
| RE SULTS
| TGFBIp is up-regulated in inflamed mouse corneas
Corneal suture placement ( Figure 1A ) was conducted to investigate the change in TGFBIp expression in the inflamed mouse cornea.
Normal corneas were used as the control. The RT-PCR and Western blotting were performed to detect the expression change in TGFBIp in mouse cornea at day 3, day 7 and day 14 after suture placement, and it was found that suture placement induced a significant up-regulation of both TGFBIp mRNA ( Figure 1C ) and protein ( Figure 1B) at days 3 and 7 after surgery. However, the expression level regressed at day 14. Similar to a previous study, 19 TGFBIp was mainly expressed in the normal corneal epithelial layer, and TGFBIp immunoreactivity was not detected in the stromal matrix of the normal cornea ( Figure 1D ). However, TGFBIp was localized to the corneal stroma at day 3, and TGFBIp expression was enhanced at day 7 after suture placement ( Figure 1E ).
| The up-regulation of TGFBIp in sutured cornea correlates with macrophage recruitment
Previous studies have verified TGFBIp is expressed at significantly elevated levels in macrophages under conditions such as stimulation by inflammation-associated cytokines 36 and phagocytosis of apoptotic cells. 37 F4/80, expressed on the surface of mature tissue macrophages as a 160-kD glycoprotein, 38 is commonly used as a macrophage marker. Similar to previous studies, 30, 39 infiltration of abundant F4/80+ cells (macrophages) was detected in mouse corneas after suture placement in our current study. The infiltrated F4/80+ cells increased significantly combined with the ingrowth of corneal lymphangiogenesis at day 3 and day 7 after suture, but the infiltrated F4/80+ cells declined at day 14 and the lymph vessels continued to grow (Figure 2A ). Furthermore, to determine whether infiltrated F4/80+ cells expressed TGFBIp in inflamed mouse corneas, vascularized corneas were harvested at 7 days after suture placement, and TGFBIp was co-stained with the macrophage marker F4/80. The results showed that the expression of TGFBIp co-localized with F4/80 ( Figure 2B ). Thus, it is reasonable to suggest that the positively staining cells might represent a possible source of TGFBIp.
To verify that the up-regulation of TGFBIp in sutured cornea correlated with macrophage recruitment, we eliminated the macrophages that infiltrated the sutured cornea via a subconjunctival injection of liposomal clodronate ( Figure S1A ), which led to decreased expression of TGFBIp ( Figure 2C ) and reduced areas of corneal lymphangiogenesis and haemangiogenesis at day 7 after suture placement ( Figure S1B ).
| TGFBIp promotes lymphangiogenesis in vitro
To investigate the role of TGFBIp in the regulation of biological behaviour of HLECs in vitro, we observed the effect of TGFBIp on HLECs' proliferation, adhesion, migration and tube formation.
Unexpectedly, TGFBIp treatment had no enhancing effect on
HLECs' proliferation ( Figure 3A ). Next, we evaluated the effect of TGFBIp on HLECs' adhesion. The adhesive cells increased significantly in the TGFBIp treatment group compared with the control group, and the promoting effect was dose-dependent ( Figure 3B ).
We also explored the role of TGFBIp on HLECs' migration with a F I G U R E 2 Up-regulation of transforming growth factor-β induced protein (TGFBIp) in sutured cornea correlates with macrophage infiltration. A, Corneal suture placement induces both the recruitment of F4/80+ cells (red) and the ingrowth of corneal lymphangiogenesis (green). Scale bar = 400 μm. B, TGFBIp (green) was co-stained with the macrophage marker F4/80 (red). Scale bar = 20 μm. C, Western blot analysis showed that macrophage elimination resulted in decreased expression of TGFBIp in the sutured cornea. *P value < .05 compared with the control, and # P value < .05 compared with day 14
wound-healing assay. The uniform scratches were made, and the migration of HLECs into the scratched area was measured 12 hours later. The addition of TGFBIp significantly enhanced HLECs' migration and wound healing in a dose-dependent manner ( Figure 3C ). In the next step, we investigated whether TGFBIp has effect on the ability of HLECs' tube formation, and found that TGFBIp treatment also promoted HLECs' tube formation in a dose-dependent manner ( Figure 3D ). FN is an important ECM protein consisting of the RGD (Arg-Gly-Asp) motif, which is essential for binding integrins that are required for adhesion and migration and tube formation 
| The effect of TGFBIp on lymphangiogenesis in vitro is mediated by the integrin α5β1-FAK pathway
It has been reported that integrins are identified as the cell receptors for TGFBIp 42, 43 ; however; the subtypes of integrin which mediate the interaction between HLECs and TGFBIp still remain undefined. Using flow cytometry, it was found that HLECs mainly express integrin subtypes including α5β1 and α4β1. 44 We initially validated that the HLECs used in the current study expressed the integrin subtypes α5β1 and α4β1 using an immunofluorescence assay ( Figure 4A ). The details of the experimental procedures are provided in Appendix S1. Thus, we sought to elucidate the roles of the integrin subtypes α5β1 and α4β1 in mediating of this important interaction between HLECs and TGFBIp. To this end, we pretreated the HLECs with blocking antibody of integrin α4β1 or α5β1, and then conducted an in vitro lymphangiogenesis assay. HLECs' migration, tube formation and adhesion enhanced by TGFBIp were inhibited by integrin α5β1 blocking antibody, but blocking integrin α4β1 showed few inhibitory effects on cellular function as shown in Figure 4B . These results indicate that TGFBIp promotes HLECs' migration, tube formation and adhesion, which could be mediated by integrin α5β1. Figure 4D ). Additionally, HLEC migration, tube formation and adhesion enhanced by TGFBIp were partially suppressed by 1 μmol/L PF-573228 ( Figure 4E) . These results suggest that the phosphorylation of FAK induced by TGFBIp is mediated by α5β1 integrin.
| TGFBIp promotes lymphatic vessel sprouting
The corneal micropocket assay ( Figure 5A ) showed that TGFBIp could not induce ingrowth of newly formed corneal lymph vessels even at a high dose up to 320 ng ( Figure 5B ). Previous studies have reported that the formation of endothelial tips is an essential process for the development of newly formed vascular networks. [45] [46] [47] Thus, we also analysed the formation of endothelial tips at frontal zone of limbus lymphatics, also termed lymphatic vessel sprouting.
Indeed, TGFBIp was able to induce lymphatic endothelial tips at the frontal zone of limbus lymphatics, as the lymphatic endothelial tips in the TGFBIp group were significantly increased compared with the sham control and normal control ( Figure 5C ). Furthermore, lymphatic vessel sprouting induced by TGFBIp occurred in a concentration-dependent manner ( Figure 5D ). Unexpectedly, TGFBIp had no inductive effect on blood endothelial tips, unlike lymphatic endothelial tips ( Figure 5E ). Next, to determine whether the lymphatic vessel sprouting was mediated by the TGFBIp-α5β1 integrin pathway, we found that the application of systemically applied integrin α5-inhibiting blocking antibodies (MFR5) significantly suppressed lymphatic endothelial tips in the corneal micropocket assay compared with the vehicle control ( Figure 5F ).
| TGFBIp and VEGF-C collaboratively promote corneal lymphangiogenesis
To explore the synergistic effect of TGFBIp on corneal LG in vivo, was stronger than VEGF-C alone ( Figure 6B ). Furthermore, the collaborative effect was eliminated by blocking the TGFBIp-α5β1 integrin pathway with MFR5 ( Figure 6D ,E).
| D ISCUSS I ON
While most studies on pathogenesis of corneal LG have focused on VEGF-C and other lymphangiogenic factors, [10] [11] [12] [13] we demonstrate herein that TGFBIp, a versatile ECM protein, is highly up-regulated in inflamed mouse corneas and mediates lymphatic sprouting in corneal lymphangiogenesis. Our results also verify that TGFBIp is critically involved in LG processes both in vivo and in vitro assays.
Further investigation of this factor may help to develop new therapeutic strategies for LG-related eye diseases, including dry eye, herpetic keratitis, transplant rejection and ocular allergy.
Previous studies have reported that the formation of endothelial tips is an essential process for the development of newly formed vascular networks. [45] [46] [47] A major finding of the current study is that TGFBIp promoted lymphatic sprouting, although TGFBIp alone could not significantly stimulate corneal lymph vessel ingrowth in vivo, which indicated that TGFBIp mainly mediated corneal lymphangiogenesis at the germination stage. The in vitro results showed TGFBIp promoted the migration, tube formation and adhesion of HLECs, but it had no effect on HLEC proliferation, potentially explaining why TGFBIp only promoted lymphatic sprouting but did not induce lymph vessel ingrowth in the mouse corneal micropocket assay. It is possible that TGFBIp plays a regulatory role in the germination stage of lymphatic sprouting but fails to participate in the subsequent stages of lymphatic remodelling and maturation.
Our current study also explored the main source of TGFBIp in inflamed mouse corneas. TGFBIp has been found to be significantly expressed in macrophages under conditions such as stimulation by inflammation-associated cytokines 36 and phagocytosis of apoptotic cells. 37 Consistent with previous studies, 30, 39, 48, 49 we showed a sig- We also showed that the in vitro effect of TGFBIp was mediated by the integrin α5β1-FAK pathway. It has been reported that integrins are identified as the cell receptors for TGFBIp, 51,52 as TGFBIp contains a highly conserved RGD peptide in the C' section, which can be identified by integrin. 53 Flow cytometry assessment has shown that HLECs mainly express integrin subtypes, including α5β1 and α4β1. 44 The downstream signalling pathways activated by TGFBIp in HLECs need further exploration. Thus, we detected the phosphorylation of possible intracellular signalling molecule FAK when TGFBIp combined with its receptor. FAK is the core signalling protein in the integrin downstream signalling pathway, which mediates cell migration and adhesion. 54, 55 Western blotting showed that the phosphoryla- the limitation of this study is that our data only showed TGFBIp-induced lymphatic vessel sprouting was regulated by integrin α5β1.
Thus, it still needs further study to verify which integrin isoform plays a more important role in the TGFBIp-induced lymphatic vessel sprouting.
The current study also reveals a really interesting phenomenon in which TGFBIp plays different roles in corneal LG vs angiogenesis.
While lymphatic vessel sprouting was induced by TGFBIp in the corneal micropocket assay, almost no blood vessel sprouting tips were found in the same model. Moreover, TGFBIp and VEGF-C could not collaboratively promote corneal angiogenesis in vivo. These results indicate that lymphatic vessels are more susceptible than blood vessels to TGFBIp stimulation. The potential mechanisms governing the disparity between LG and angiogenesis responses also need further investigation.
In conclusion, the current study suggests that TGFBIp plays a critical role in corneal LG processes via four probable mechanisms. 
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